Raymond W. Tennant
#166,237
Most Influential Person Now
Raymond W. Tennant's AcademicInfluence.com Rankings
Raymond W. Tennantmedical Degrees
Medical
#3424
World Rank
#3892
Historical Rank
Toxicology
#49
World Rank
#53
Historical Rank
Download Badge
Medical
Raymond W. Tennant's Degrees
- PhD Toxicology University of North Carolina at Chapel Hill
- Masters Toxicology University of North Carolina at Chapel Hill
- Bachelors Biology University of North Carolina at Chapel Hill
Similar Degrees You Can Earn
Why Is Raymond W. Tennant Influential?
(Suggest an Edit or Addition)Raymond W. Tennant's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. (1987) (784)
- Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. (1988) (702)
- Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. (1991) (669)
- Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. (2003) (578)
- Standardizing global gene expression analysis between laboratories and across platforms (2005) (410)
- Gene expression analysis reveals chemical-specific profiles. (2002) (277)
- Prediction of compound signature using high density gene expression profiling. (2002) (261)
- Identification of putative gene based markers of renal toxicity. (2004) (255)
- Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. (1995) (253)
- Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. (1998) (246)
- Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals (1990) (235)
- Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 39 chemicals tested for carcinogenicity by the U.S. National Toxicology Program. (1991) (220)
- Gene expression profiling of rat livers reveals indicators of potential adverse effects. (2004) (217)
- Inhibition of leukaemia virus replication by polyadenylic acid. (1972) (152)
- CEBS—Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data (2007) (145)
- CD34 expression by hair follicle stem cells is required for skin tumor development in mice. (2007) (141)
- Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. (1993) (135)
- Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. (1996) (131)
- Blood gene expression signatures predict exposure levels (2007) (130)
- Methapyrilene Toxicity: Anchorage of Pathologic Observations to Gene Expression Alterations (2002) (129)
- Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. (2002) (112)
- Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the National Toxicology Program. (1990) (112)
- Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays. (1993) (110)
- Prediction of rodent carcinogenicity for 44 chemicals: results. (1994) (98)
- Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. (2008) (96)
- The National Center for Toxicogenomics: using new technologies to inform mechanistic toxicology. (2002) (96)
- Effect of Cell Physiological State on Infection by Rat Virus (1969) (92)
- T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity. (1997) (92)
- Biology of radiation carcinogenesis (1976) (90)
- Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor. (2005) (90)
- Toxicogenomic approach for assessing toxicant-related disease. (2003) (87)
- Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells. (1980) (87)
- Responses of transgenic mouse lines p53(+/-) and Tg.AC to agents tested in conventional carcinogenicity bioassays. (2000) (82)
- Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard. (1993) (80)
- Follicular origin of epidermal papillomas in v-Ha-ras transgenic TG.AC mouse skin. (1994) (77)
- Global Gene Expression Associated with Hepatocarcinogenesis in Adult Male Mice Induced by in Utero Arsenic Exposure (2005) (75)
- Transponder-Induced Sarcoma in the Heterozygous p53+/- Mouse (1999) (75)
- Study design and sample sizes for a lacl transgenic mouse mutation assay (1995) (71)
- Genetically altered mouse models for identifying carcinogens. (1999) (71)
- Cadmium-induced toxicity in rat primary mid-brain neuroglia cultures: role of oxidative stress from microglia. (2007) (70)
- Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment (2000) (68)
- Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. (2001) (61)
- Requirement of cellular synthesis for Kilham rat virus replication. (1970) (61)
- Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program. (1989) (60)
- Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses (1983) (58)
- Focal transgene expression associated with papilloma development in v‐Ha‐ras–transgenic TG.AC mice (1994) (58)
- Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice. (1999) (57)
- Kinetics of wound‐induced v‐Ha‐ras transgene expression and papilloma development in transgenic Tg.AC mice (1997) (56)
- Gene expression response in target organ and whole blood varies as a function of target organ injury phenotype (2008) (53)
- Prevalence of viruses in mouse colonies. (1966) (53)
- Transgenic animals in toxicology. (1994) (49)
- Evidence that toxic injury is not always associated with induction of chemical carcinogenesis (1991) (48)
- Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. (2007) (48)
- Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma. (1972) (48)
- VIRUS STUDIES WITH GERMFREE MICE. I. PREPARATION OF SEROLOGIC DIAGNOSTIC REAGENTS AND SURVEY OF GERMFREE AND MONOCONTAMINATED MICE FOR INDIGENOUS MURINE VIRUSES. (1965) (47)
- Comparison of multiple parameters of rodent carcinogenicity and in vitro genetic toxicity. (1986) (47)
- The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model (2001) (47)
- Predicting Rodent Carcinogenicity from Four in vitro Genetic Toxicity Assays: An Evaluation of 114 Chemicals Studied by the National Toxicology Program (1990) (46)
- Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice. (1996) (46)
- Tg.AC Genetically Altered Mouse: Assay Working Group Overview of Available Data (2001) (46)
- Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation. (2008) (43)
- Alternatives to using human experience in assessing health risks. (1987) (42)
- Genetic toxicology: current status of methods of carcinogen identification. (1993) (42)
- Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice. (1998) (42)
- Photocarcinogenesis and susceptibility to UV radiation in the v-Ha-ras transgenic Tg.AC mouse. (1998) (40)
- Suppressive effect of immunization with mouse fetal antigens on growth of cells infected with Rauscher leukemia virus and plasma-cell tumors. (1971) (39)
- Reversal of Fv-1 host range by in vitro restriction endonuclease fragment exchange between molecular clones of N-tropic and B-tropic murine leukemia virus genomes (1983) (39)
- An interlaboratory evaluation of the Syrian hamster embryo cell transformation assay using eighteen coded chemicals. (1988) (38)
- Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment. (2000) (37)
- Mutagenesis, clastogenesis, carcinogenesis: expectations, correlations and relations. (1986) (37)
- Effects of Polyadenylic Acids on Functions of Murine RNA Tumor Viruses (1973) (35)
- Enzootic Sendai Virus Infections in Mouse Breeder Colonies within the United States (1964) (33)
- Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors (2004) (33)
- Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure. (1993) (33)
- Reciprocal inhibition of mouse leukemia virus infection by Fv-1 allele cell extracts. (1974) (33)
- Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue. (1993) (32)
- Identification of Dss1 as a 12-O-Tetradecanoylphorbol-13-acetate-responsive Gene Expressed in Keratinocyte Progenitor Cells, with Possible Involvement in Early Skin Tumorigenesis* (2003) (32)
- Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. (1995) (29)
- Chemical enhancement of SA7 virus transformation of hamster embryo cells: evaluation by interlaboratory testing of diverse chemicals. (1986) (29)
- Predicting chemical carcinogenesis in rodents. (1993) (28)
- Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse. (2001) (27)
- Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review (2005) (27)
- Induction of transgene expression in Tg.AC (v‐Ha‐ras) transgenic mice concomitant with DNA hypomethylation (1998) (27)
- A perspective on nonmutagenic mechanisms in carcinogenesis. (1993) (26)
- 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies and conceptual issues. (1998) (26)
- Induction of retrovirus gene expression in mouse cells by some chemical mutagens. (1982) (26)
- Mouse strains for chemical carcinogenicity studies: overview of a workshop. (1988) (25)
- Comprehensive microarray transcriptome profiling of CD34-enriched mouse keratinocyte stem cells. (2007) (24)
- Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis. (2009) (24)
- Molecular structure and characterization of a novel murine ABC transporter, Abca13. (2003) (23)
- Effect of the Fv‐1 gene on leukemia virus in mouse cell heterokaryons (1974) (22)
- Statistical analysis of skin tumor data from Tg.AC mouse bioassays. (2000) (22)
- Selective growth of some rodent epithelial cells in a medium containing citrulline. (1979) (22)
- Comparative evaluation of genetic toxicity patterns of carcinogens and noncarcinogens: strategies for predictive use of short-term assays. (1987) (21)
- Evaluation and validation issues in the development of transgenic mouse carcinogenicity bioassays. (1998) (20)
- Toward a checklist for exchange and interpretation of data from a toxicology study. (2007) (20)
- The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity. (1991) (20)
- In vitro quantitation of lethal and physiologic effects of total body irradiation on stromal and hematopoietic stem cells in continuous bone marrow cultures from Rf mice. (1982) (20)
- Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens. (1996) (19)
- Ultraviolet photobiology of Kilham rat virus and the absolute ultraviolet photosensitivities of other animal viruses: influence of DNA strandedness, molecular weight, and host-cell repair. (1972) (19)
- Ability of short-term tests to predict carcinogenesis in rodents. (1990) (19)
- Characterization of Fv-1 host range strains of murine retroviruses by titration and p30 protein characteristics. (1979) (19)
- Mammalian cell transformation. Mechanisms of carcinogenesis and assays for carcinogens. (1985) (19)
- Hemizygous Tg.AC transgenic mouse as a potential alternative to the two‐year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors (1998) (19)
- Inhibition of murine RNA tumor virus replication and oncogenesis by chloroquine (1974) (19)
- Cell division requirement for activation of murine leukemia virus in cell culture by irradiation. (1976) (19)
- Effects of nitrosocarbaryl on BALB/3T3 cells. (1975) (18)
- Respiratory virus infections of mice. (1966) (18)
- 12-O-Tetradecanoylphorbol-13-acetate and UV Radiation-induced Nucleoside Diphosphate Protein Kinase B Mediates Neoplastic Transformation of Epidermal Cells* (2004) (17)
- Effect of the viable-yellow (A(vy)) agouti allele on skin tumorigenesis and humoral hypercalcemia in v-Ha-ras transgenic TGxAC mice. (1998) (17)
- Photocarcinogenesis in the Tg.AC Mouse: Lomefloxacin and 8-Methoxypsoralen¶,† (2003) (16)
- A novel role for the T‐box transcription factor Tbx1 as a negative regulator of tumor cell growth in mice (2011) (16)
- In vitro transformation of Syrian hamster epidermal cells by N-methyl-N'-nitro-N-nitrosoguanidine. (1981) (16)
- Cytogenetic analysis of malignant skin tumors induced in chemically treated TG.AC transgenic mice (1994) (16)
- A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event. (1995) (16)
- Transfection of Fv-1 permissive and restrictive mouse cells with integrated DNA of murine leukemia viruses. (1978) (15)
- Radial transformation-associated recombination cloning from the mouse genome: isolation of Tg.AC transgene with flanking DNAs. (2000) (15)
- Decreases in phorbol ester–induced papilloma development in v‐Ha‐ras transgenic TG.AC mice during reduced gene dosage of bcl‐2 (1997) (15)
- Morphological Characterization of Spindle Cell Tumors Induced in Transgenic Tg.AC Mouse Skin (1998) (14)
- Prevention of Infectious Diseases in Experimental Mice.∗ (1967) (14)
- Pneumonia Virus of Mice (PVM) in Cell Culture.∗ (1962) (14)
- What is a tumor promoter? (1999) (14)
- Effect of 5-fluorouracil on the multiplication of a virulent virus (pseudorabies) and an oncogenic virus (polyoma). (1967) (14)
- Inhibition of Mitosis and Macromolecular Synthesis in Rat Embryo Cells by Kilham Rat Virus (1971) (13)
- The transgenic Tg.AC mouse model for identification of chemical carcinogens. (1998) (13)
- Analysis of recombinant DNA clones of the endogenous BALB/c murine leukemia virus WN1802N: variation in long terminal repeat length (1983) (13)
- The variable influence of host microflora and intercurrent infections on immunological competence and carcinogenesis. (1973) (12)
- Effects of poly(2'-O-methyladenylic acid) on susceptibility and autogenous immunity to RNA tumor virus oncogenesis in vivo. (1974) (12)
- Molecular Cloning and Analysis of the Endogenous Retrovirus Chemically Induced from RFM/Un Mouse Cell Cultures (1983) (12)
- Chemical enhancement of survival in aggregation of retrovirus-infected rat cells: an interlaboratory comparison. (1985) (12)
- Transfer of Fv-1 locus-specific resistance to murine N-tropic and B-tropic retroviruses by cytoplasmic RNA (1978) (11)
- Murine Leukemia Virus: Restriction in Fused Permissive and Nonpermissive Cells (1972) (11)
- A farnesyl transferase inhibitor suppresses TPA‐mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse (2000) (11)
- Relationships between in Vitro Genetic Toxicity and Carcinogenidty Studies in Animals (1988) (11)
- Mechanism of skin tumorigenesis by contact sensitizers: the effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4 dinitro-1-fluorobenzene in the skin of the TG.AC (v-Ha-ras) mouse. (1996) (11)
- Addendum: Standardizing global gene expression analysis between laboratories and across platforms (2005) (10)
- Induction of endogenous murine retrovius by hydroxyurea and related compounds. (1978) (10)
- Genetic evidence for a product of the Fv-1 locus that transfers resistance to mouse leukemia viruses (1976) (10)
- TGFα is Dispensable for Skin Tumorigenesis in Tg.AC Mice (1998) (10)
- Photocarcinogenesis in the Tg.AC Mouse: Lomefloxacin and 8‐Methoxypsoralen ¶ † (2003) (10)
- Transgenic mice in carcinogenicity testing. (1992) (10)
- VIRUS STUDIES WITH GERMFREE MICE. II. COMPARATIVE RESPONSES OF GERMFREE MICE TO VIRUS INFECTION. (1965) (9)
- Evidence for a Stable Intermediate in Leukemia Virus Activation in AKR Mouse Embryo Cells (1974) (9)
- Commentary on the status of short‐term tests for chemical carcinogens (1988) (9)
- Effect of the Fv-1 locus in vivo: host range pseudotypes of murine sarcoma virus. (1978) (9)
- Analysis of Proteins of Mouse Sarcoma Pseudotype Viruses: Type-Specific Radioimmunoassays for Ecotropic Virus p30's (1979) (9)
- Analysis of the interlaboratory and intralaboratory reproducibility of the enhancement of simian adenovirus SA7 transformation of Syrian hamster embryo cells by model carcinogenic and noncarcinogenic compounds. (1986) (8)
- Comparative evaluation of three mammalian cell transformation assay systems. (1985) (8)
- Identification of genes and gene ontology processes critical to skin papilloma development in Tg.AC transgenic mice (2006) (7)
- Transgenic Rodent Models (1999) (7)
- The 20th Aspen Cancer Conference: Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention, and Cancer Therapy 2005 (2008) (7)
- Synthesis and circularization of Nand B-tropic retroviral DNA in Fv-1 permissive and restrictive mouse cells ( host range restriction / viral DNA maturation / mouse Fv-1 locus ) (7)
- Involvement of DNA damage in hydroxyurea-mediated induction of endogenous murine retrovirus. (1979) (7)
- Oral administration of dimethylvinyl chloride increases frequency of forestomach papillomas in Tg.AC mice (2000) (7)
- Mechanisms in endogenous leukemia virus induction by radiation and chemicals (1976) (7)
- Some similarities in the responses of mice to pregnancy and leukemogenesis (1972) (6)
- Gene manipulation and genetic toxicology. (1994) (6)
- CD34 Antigen: Determination of Specific Sites of Phosphorylation In Vitro and In Vivo. (2011) (6)
- Mechanisms of cocarcinogenesis involving endogenous retroviruses. (1980) (6)
- Immunofluorescent analysis of murine leukemia virus-infected cells by flow microfluorometry. (1978) (6)
- Shock toxicology with transgenics (1997) (6)
- The use of transgenic animals in cancer testing. (1999) (6)
- Transgenic assays and the identification of carcinogens (2001) (5)
- Transgenic mouse models in chemical carcinogenesis studies. (1994) (5)
- Mutagens and carcinogens (2014) (5)
- Twelfth International Conference on Carcinogenesis and Risk Assessment Gene Environment Interactions: Emerging issues, technologies, and biological paradigms (2000) (5)
- Rapid screening for chemical carcinogens: transforming activity of selected nitroso compounds detected in a transplacental host-mediated culture system. (1979) (5)
- Hematopoietic neoplasias of the RFM/Un mouse contain somatic re-integration of the restriction endogenous ecotropic provirus. (1986) (5)
- Chemical enhancement of SA7 virus transformation of hamster embryo cells: interlaboratory testing of diverse chemicals. (1985) (4)
- Spontaneous stem cell leukemia in young Sprague-Dawley rats. (1972) (4)
- Restriction of murine leukemia viruses by Fv-1: a model for studying host genetic control of retroviral gene movement and leukemogenesis. (1983) (4)
- Issues in biochemical applications to risk assessment: are short-term tests predictive of in vivo tumorigenicity? (1987) (4)
- Control of RFM strain endogenous retrovirus in RFM mouse cells (1983) (4)
- TGF alpha is dispensable for skin tumorigenesis in Tg.AC mice. (1998) (4)
- Sixth aspen cancer conference: Molecular mechanisms of genetic deregulation in toxicity and carcinogenesis (1993) (3)
- Morphological transformation of Syrian hamster embryo cells by mezerein. (1992) (3)
- Prediction of Chemical Carcinogenicity in (2016) (3)
- Response: do short-term tests predict rodent carcinogenicity? (1988) (3)
- Suppressive Effect of Immunization with Mouse Fetal Antigens on Growth of Cells Infected with Rauscher Leukemia Virus and on Plasma-Cell Tumors ( fetal neoantigens ) (3)
- Endogenous retrovirus and radiation-induced leukemia in the RFM mouse. (1983) (2)
- A method for accelerating progression to a malignant phenotype in rodent cells. (1987) (2)
- Responses of Transgenic Mouse Lines p 53 1 / 2 and Tg z AC to Agents Tested in Conventional Carcinogenicity Bioassays (2000) (2)
- Seventeenth Aspen Cancer Conference: mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy (2003) (2)
- A perspective on measurement of mutations in vivo (1991) (2)
- by Inhibition of the Epidermal Growth Factor Receptor Chemoprevention of UV Light-Induced Skin Tumorigenesis (2005) (2)
- Genomics and Environmental Regulation: Science, Ethics and Law (2009) (2)
- Eighth aspen cancer conference: Molecular mechanisms of toxicity in relation to the genetics of animal and human neoplasia (1994) (2)
- Transformation of BALB/c-3T3 Cells: Introduction (1993) (2)
- New animals, new uses, and old issues (1996) (2)
- INTERACTION OF RNA TUMOR VIRUSES AND THE IMMUNE SYSTEM: IMMUNE CAPACITY AND PATHOGENESIS. (1972) (1)
- Assay of mouse-cell clones for retrovirus p30 protein by use of an automated solid-state radioimmunoassay. (1979) (1)
- Serological studies with an agent of epizootic diarrhea of infant mice. (1966) (1)
- The TG cntdot AC transgenic mouse line An important in vivo short term test model for identifying nongenotoxic carcinogens (1995) (1)
- Twelfth Aspen cancer conference: Mechanisms of toxicity and carcinogenesis (1998) (1)
- Increased carcinogen metabolism and survival of retrovirus-infected Fischer rat embryo cells following repetitive carcinogen treatment. (1985) (1)
- Argininosuccinate synthetase as a marker of transformed Syrian hamster epidermal cells. (1980) (1)
- Nongenotoxic Chemical Carcinogens: Evidence for Multiple Mechanisms (1994) (1)
- Eighteenth Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy (2003) (1)
- Characterization of Fv-1 gene-product-mediated resistance transfer. (1981) (1)
- RADIATION-INDUCED IMMUNOSUPPRESSION: DEMONSTRATION OF ITS ROLE IN RADIATION LEUKEMOGENESIS IN THE INTACT RF MOUSE. (1972) (1)
- TOXICOLOGICAL HIGHLIGHT Gene Expression Analysis Reveals Chemical-Specific Profiles (2002) (1)
- Fv-1 locus restriction of mouse retroviruses in glucocorticoid-treated cells. (1978) (1)
- Tenth International Conference on Carcinogenesis and Risk Assessment: “New approaches for assessing the carcinogenic potential of chemicals” (1997) (0)
- Mammalian cell transformation assays: what role can they play in the identification of carcinogens? (1986) (0)
- Chapter 16 – Mouse Adenovirus (1982) (0)
- Effects of total body irradiation on long-term hematopoiesis in bone marrow cultures derived from leukemia-prone rfm/un mice. Abstr. (1981) (0)
- Highly repetitive chromosome changes associated with skin tumor development in transgenic mice treated with TPA (1993) (0)
- Current status of transgenic bioassays for carcinogens (1998) (0)
- Biochemical characterization of fv-1 allele cell extracts inhibiting mouse leukemia virus infection. Abstr. (1975) (0)
- Tumor Promoters: Tennant's Response (1999) (0)
- Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, and cancer prevention (2001) (0)
- The National Toxicogenomics Program (2005) (0)
- Use of a transplacental host-mediated culture system for assay of transformation by nitroso compounds (1975) (0)
- Gene Expression Profiling of Transplacental Arsenic Carcinogenesis in Mice (2008) (0)
- Fifteenth Aspen Cancer Conference: mechanisms of toxicity, carcinogenesis, and cancer prevention. (2001) (0)
- O XV B.1 Transgenic mouse models as tools to define specific chemical-gene interactions (1997) (0)
- Letters to the Editors (0)
- Evidence for an immune response to endogenous rna tumor in rfm mice. Abstr. (1972) (0)
- Viruses by titration and p30 protein characteristics. (1979) (0)
- Effects ofPolyadenylic Acids on Functions of MurineRNA TumorViruses (1973) (0)
- Ninth aspen cancer conference: Mechanisms of toxicity and carcinogenesis (1995) (0)
- Kinetics of repair of total body irradiation damage to marrow stromal cells quantitated in vitro by hematopoiesis and leukemogenesis in long-term bone marrow cultures (1981) (0)
- Carcinogenicity and Genetic Toxicity Results on Single Chemicals : Implications for Testing Mixtures (2006) (0)
- Specific cell RNA mediators and the mechanism of Fv-1 gene restriction (1977) (0)
- Taxonomy of murine viruses. (1966) (0)
- Synthesis and circularization of viral dna in fv-1 permissive and restrictive mouse cells infected with n-tropic and b-tropic retroviruses. Abstr. (1980) (0)
- Tenth Aspen Cancer Conference: Mechanisms of toxicity and carcinogenesis (1996) (0)
- Tumor virus envelope antigens and virus-induced cell surface antigens. (1975) (0)
- Variation of long-terminal-repeat size in molecular clones of the BALB/c endogenous ecotropic murine leukemia virus. (1983) (0)
- Selective growth ofsomerodent epithelial cells inamediumcontaining citrulline (1979) (0)
- The Nineteenth Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy, 2004 (2005) (0)
- Studies by dna transfection. Abstr. (1977) (0)
- DNA replication of the parvovirus Kilham rat virus. I. Characterization of intracellular forms of viral DNA extracted by guanidine hydrochloride (1977) (0)
- Effects of polyadenylic acids on transformation and activation of mouse rna tumor viruses. Abstr. (1973) (0)
- Fourth Aspen Cancer Conference Carcinogenesis—From Molecular Mechanisms to Molecular Epidemiology (1990) (0)
- Ecotropic host range pseudotypes of murine sarcoma virus effect of the fv 1 locus in vivo (1977) (0)
- Computation of DNA synthesis rates from flow microfluorometric histograms. I. Theory (1976) (0)
- AN ovelGJB2 (Connexin 26) Mutation, F142L, in a Patient with Unusual Mucocutaneous Findings and Deafness (2003) (0)
- Sixteenth Aspen cancer conference: Mechanisms of carcinogenesis, cancer prevention, and cancer therapy (2002) (0)
- In vitro cytotoxicity of embryonal antigen primed spleen cells vs cells infected with moloney leukemia virus. Abstr. (1971) (0)
- Activation of murine leukemia virus by gamma irradiation. Abstr. (1975) (0)
- Variation of LTR size in molecular clones of the BALB/c endogenous ecotropic molecular leukemia virus (1982) (0)
- Effect of mutant ras on gene expression patterns in pre-neoplastic mouse epidermal stem cells (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Raymond W. Tennant?
Raymond W. Tennant is affiliated with the following schools:
